These findings suggest that benzoquinone (121) exerts a protective effect against STZ-induced hyperglycemia, and the underlying molecular mechanism of its impact could be associated with the suppression of the activation of the TLR4/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and Hyperglycemia.